These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3773924)

  • 1. [Official declaration of the German Society of Pediatrics and the German Society of Pediatric and Adolescent Psychiatry on the use of psychotropic drugs in children. Prescribing stimulants for children].
    Martinius J; Bläker F
    Monatsschr Kinderheilkd; 1986 Aug; 134(8):558. PubMed ID: 3773924
    [No Abstract]   [Full Text] [Related]  

  • 2. [Official declaration of the German Society of Child and Adolescent Psychiatry on the topic of a low phosphate diet in children with hyperkinetic syndrome. Position of the German Society of Child and Adolescent Psychiatry and the German Society of Pediatrics on the topic of the so-called phosphate-reduced diet as a help for children with the hyperkinetic syndrome].
    Martinius J; Bläker F
    Monatsschr Kinderheilkd; 1986 Sep; 134(9):703-4. PubMed ID: 3785239
    [No Abstract]   [Full Text] [Related]  

  • 3. ECGs before stimulants in children.
    Med Lett Drugs Ther; 2008 Jul; 50(1291):60. PubMed ID: 18654112
    [No Abstract]   [Full Text] [Related]  

  • 4. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adderall and other drugs for attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1994 Nov; 36(936):109-10. PubMed ID: 7968783
    [No Abstract]   [Full Text] [Related]  

  • 6. Age-related changes in motor subtle signs among girls and boys with ADHD.
    Poulton A; Nanan R
    Neurology; 2009 Oct; 73(15):1248; author reply 1248-9. PubMed ID: 19822879
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention deficit/hyperactivity disorder and psychopharmacologic treatments in the athlete.
    Conant-Norville DO; Tofler IR
    Clin Sports Med; 2005 Oct; 24(4):829-43, viii. PubMed ID: 16169448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.
    Torres AR; Whitney J; Gonzalez-Heydrich J
    Epilepsy Behav; 2008 Feb; 12(2):217-33. PubMed ID: 18065271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention deficit-hyperactivity disorder not just for children anymore.
    Edwards A
    Adv Nurse Pract; 1999 May; 7(5):47-50. PubMed ID: 10578734
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adderall: the newest available option in ADHD.
    Adv Nurse Pract; 1997 Jun; 5(6):73-4. PubMed ID: 9459934
    [No Abstract]   [Full Text] [Related]  

  • 14. Adderall XR: long acting stimulant for single daily dosing.
    Sallee FR; Smirnoff AV
    Expert Rev Neurother; 2004 Nov; 4(6):927-34. PubMed ID: 15853519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
    Marcus SC; Wan GJ; Kemner JE; Olfson M
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication for children with attentional disorders. American Academy of Pediatrics Committee on Children With Disabilities and Committee on Drugs.
    Pediatrics; 1996 Aug; 98(2 Pt 1):301-4. PubMed ID: 8692637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hyperactive child.
    Muiva PM
    East Afr Med J; 1979 May; 56(5):237-40. PubMed ID: 467294
    [No Abstract]   [Full Text] [Related]  

  • 18. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.
    Wigal SB; McGough JJ; McCracken JT; Biederman J; Spencer TJ; Posner KL; Wigal TL; Kollins SH; Clark TM; Mays DA; Zhang Y; Tulloch SJ
    J Atten Disord; 2005 Aug; 9(1):275-89. PubMed ID: 16371674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting.
    Swanson J; Wigal S; Greenhill L; Browne R; Waslick B; Lerner M; Williams L; Flynn D; Agler D; Crowley KL; Fineberg E; Regino R; Baren M; Cantwell D
    Psychopharmacol Bull; 1998; 34(1):55-60. PubMed ID: 9564199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trend and area variation in amphetamine prescription usage among children and adolescents in Michigan.
    Lin SJ; Crawford SY; Lurvey PL
    Soc Sci Med; 2005 Feb; 60(3):617-26. PubMed ID: 15550309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.